|
1
|
Hotchkiss RS and Nicholson DW: Apoptosis
and caspases regulate death and inflammation in sepsis. Nat Rev
Immunol. 6:813–822. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ikeda T: Idiosyncratic drug
hepatotoxicity: Strategy for prevention and proposed mechanism.
Curr Med Chem. 22:528–537. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yan J and Li S and Li S: The role of the
liver in sepsis. Int Rev Immunol. 33:498–510. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gómez-Lechón MJ, Lahoz A, Gombau L,
Castell JV and Donato MT: In vitro evaluation of potential
hepatotoxicity induced by drugs. Curr Pharm Des. 16:1963–1977.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li X, Akhtar S, Kovacs EJ, Gamelli RL and
Choudhry MA: Inflammatory response in multiple organs in a mouse
model of acute alcohol intoxication and burn injury. J Burn Care
Res. 32:489–497. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fausto N, Campbell JS and Riehle KJ: Liver
regeneration. Hepatology. 43 2 Suppl 1:S45–S53. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fausto N and Campbell JS: The role of
hepatocytes and oval cells in liver regeneration and repopulation.
Mech Dev. 120:117–130. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Michalopoulos GK and DeFrances MC: Liver
regeneration. Science. 276:60–66. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hardie DG, Ross FA and Hawley SA: AMPK: A
nutrient and energy sensor that maintains energy homeostasis. Nat
Rev Mol Cell Biol. 13:251–262. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yamamoto T, Kojima T, Murata M, Takano K,
Go M, Hatakeyama N, Chiba H and Sawada N: p38 MAP-kinase regulates
function of gap and tight junctions during regeneration of rat
hepatocytes. J Hepatol. 42:707–718. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yan XP, Wang S, Yang Y and Qiu YD: Effects
of n-3 polyunsaturated fatty acids on rat livers after partial
hepatectomy via LKB1-AMPK signaling pathway. Transplant Proc.
43:pp. 3604–3612. 2011; View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li G and G LG: Farnesoid X receptor, the
bile acid sensing nuclear receptor, in liver regeneration. Acta
Pharm Sin B. 5:93–98. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li SQ, Zhu S, Wan XD, Xu ZS and Ma Z:
Neutralization of ADAM8 ameliorates liver injury and accelerates
liver repair in carbon tetrachloride-induced acute liver injury. J
Toxicol Sci. 39:339–351. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun H, Zhu X, Lin W, Zhou Y, Cai W and Qiu
L: Interactions of TLR4 and PPARγ, dependent on AMPK signalling
pathway contribute to anti-inflammatory effects of vaccariae
hypaphorine in endothelial cells. Cell Physiol Biochem.
42:1227–1239. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang L, Fang Y, Cheng X, Lian Y, Xu H,
Zeng Z and Zhu H: TRPML1 participates in the progression of
alzheimer's disease by regulating the PPARγ/AMPK/Mtor signalling
pathway. Cell Physiol Biochem. 43:2446–2456. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang F, Zhang L, Gao Z, Sun X, Yu M, Dong
S, Wu J, Zhao Y, Xu C, Zhang W and Lu F: Exogenous H2S protects
against diabetic cardiomyopathy by activating autophagy via the
AMPK/mTOR pathway. Cell Physiol Biochem. 43:1168–1187. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kemp BE, Mitchelhill KI, Stapleton D,
Michell BJ, Chen ZP and Witters LA: Dealing with energy demand: The
AMP-activated protein kinase. Trends Biochem Sci. 24:22–25. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Varela-Rey M, Beraza N, Lu SC, Mato JM and
Martinez-Chantar ML: Role of AMP-activated protein kinase in the
control of hepatocyte priming and proliferation during liver
regeneration. Exp Biol Med (Maywood). 236:402–408. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Merlen G, Gentric G, Celton-Morizur S,
Foretz M, Guidotti JE, Fauveau V, Leclerc J, Viollet B and
Desdouets C: AMPKα1 controls hepatocyte proliferation independently
of energy balance by regulating Cyclin A2 expression. J Hepatol.
60:152–159. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park HU, Suy S, Danner M, Dailey V, Zhang
Y, Li H, Hyduke DR, Collins BT, Gagnon G, Kallakury B, et al:
AMP-activated protein kinase promotes human prostate cancer cell
growth and survival. Mol Cancer Ther. 8:733–741. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Peralta S, Garcia S, Yin HY, Arguello T,
Diaz F and Moraes CT: Sustained AMPK activation improves muscle
function in a mitochondrial myopathy mouse model by promoting
muscle fiber regeneration. Hum Mol Genet. 25:3178–3191. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cotan D, Paz MV, Alcocer-Gomez E,
Garrido-Maraver J, Oropesa-Ávila M, de la Mata M, Pavón AD, de
Lavera I, Galán F, Ybot-González P and Sánchez-Alcázar JA: AMPK as
a target in rare diseases. Curr Drug Targets. 17:921–931. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li X, Liu R, Zhang L and Jiang Z: The
emerging role of AMP-activated protein kinase in cholestatic liver
diseases. Pharmacol Res. 125:105–113. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Woods A, Williams JR, Muckett PJ, Mayer
FV, Liljevald M, Bohlooly-Y M and Carling D: Liver-specific
activation of AMPK prevents steatosis on a high-fructose diet. Cell
Rep. 18:3043–3051. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liang Z, Li T, Jiang S, Xu J, Di W, Yang
Z, Hu W and Yang Y: AMPK: A novel target for treating hepatic
fibrosis. Oncotarget. 8:62780–62792. 2017.PubMed/NCBI
|
|
26
|
Yang C, Gong X, Ai Q, Ge P, Lin L and
Zhang L: 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside
alleviated carbon tetrachloride-induced acute hepatitis in mice.
Int Immunopharmacol. 25:393–399. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou D, Ai Q, Lin L, Gong X, Ge P, Che Q,
Wan J, Wen A and Zhang L:
5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-attenuates
LPS/D-Gal-induced acute hepatitis in mice. Innate Immun.
21:698–705. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang M, Yang D, Gong X, Ge P, Dai J, Lin
L and Zhang L: Protective benefits of AMP-activated protein kinase
in hepatic ischemia-reperfusion injury. Am J Transl Res. 9:823–829.
2017.PubMed/NCBI
|
|
29
|
Jin J, Mullen TD, Hou Q, Bielawski J,
Bielawska A, Zhang X, Obeid LM, Hannun YA and Hsu YT: AMPK
inhibitor Compound C stimulates ceramide production and promotes
Bax redistribution and apoptosis in MCF7 breast carcinoma cells. J
Lipid Res. 50:2389–2397. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou G, Myers R, Li Y, Chen Y, Shen X,
Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, et al: Role of
AMP-activated protein kinase in mechanism of metformin action. J
Clin Invest. 108:1167–1174. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yuan H, Li L, Zheng W, Wan J, Ge P, Li H
and Zhang L: Antidiabetic drug metformin alleviates
endotoxin-induced fulminant liver injury in mice. Int
Immunopharmacol. 12:682–688. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shackelford DB and Shaw RJ: The LKB1-AMPK
pathway: Metabolism and growth control in tumour suppression. Nat
Rev Cancer. 9:563–575. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vazquez-Martin A, López-Bonet E,
Oliveras-Ferraros C, Pérez-Martínez MC, Bernadó L and Menendez JA:
Mitotic kinase dynamics of the active form of AMPK
(phospho-AMPKalphaThr172) in human cancer cells. Cell Cycle.
8:788–791. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vazquez-Martin A, Oliveras-Ferraros C,
Cufi S and Menendez JA: Polo-like kinase 1 regulates activation of
AMP-activated protein kinase (AMPK) at the mitotic apparatus. Cell
Cycle. 10:1295–1302. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vazquez-Chantada M, Ariz U, Varela-Rey M,
Embade N, Martínez-Lopez N, Fernández-Ramos D, Gómez-Santos L,
Lamas S, Lu SC, Martínez-Chantar ML and Mato JM: Evidence for
LKB1/AMP-activated protein kinase/endothelial nitric oxide synthase
cascade regulated by hepatocyte growth factor, S-adenosylmethionine
and nitric oxide in hepatocyte proliferation. Hepatology.
49:608–617. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cai L, Hu K, Lin L, Ai Q, Ge P, Liu Y, Dai
J, Ye B and Zhang L: AMPK dependent protective effects of metformin
on tumor necrosis factor-induced apoptotic liver injury. Biochem
Biophys Res Commun. 465:381–386. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang T, Guo P, Zhang Y, Xiong H, Yu X, Xu
S, Wang X, He D and Jin X: The antidiabetic drug metformin inhibits
the proliferation of bladder cancer cells in vitro and in vivo. Int
J Mol Sci. 14:24603–24618. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Qi H, Liu Y, Li S, Chen Y, Li L, Cao YE M,
Shi P, Song C, Li B and Sun H: Activation of AMPK attenuated
cardiac fibrosis by inhibiting CDK2 via p21/p27 and miR-29 family
pathways in rats. Mol Ther Nucleic Acids. 8:277–290. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu PF, Hsu CJ, Tsai WL, Cheng JS, Chen
JJ, Huang IF, Tseng HH, Chang HW and Shu CW: Ablation of ATG4B
suppressed autophagy and activated AMPK for cell cycle arrest in
cancer cells. Cell Physiol Biochem. 44:728–740. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang WL, Perillo W, Liou D, Marambaud P
and Wang P: AMPK inhibitor compound C suppresses cell proliferation
by induction of apoptosis and autophagy in human colorectal cancer
cells. J Surg Oncol. 106:680–688. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Viswakarma N, Jia Y, Bai L, Gao Q, Lin B,
Zhang X, Misra P, Rana A, Jain S, Gonzalez FJ, et al: The Med1
subunit of the mediator complex induces liver cell proliferation
and is phosphorylated by AMP kinase. J Biol Chem. 288:27898–27911.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Vucicevic L, Misirkic M, Janjetovic K,
Harhaji-Trajkovic L, Prica M, Stevanovic D, Isenovic E, Sudar E,
Sumarac-Dumanovic M, Micic D and Trajkovic V: AMP-activated protein
kinase-dependent and -independent mechanisms underlying in vitro
antiglioma action of compound C. Biochem Pharmacol. 77:1684–1693.
2009. View Article : Google Scholar : PubMed/NCBI
|
